406
Views
18
CrossRef citations to date
0
Altmetric
Review

Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)

, , , , , , , , , & show all
Pages 757-766 | Received 02 Mar 2016, Accepted 17 May 2016, Published online: 13 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Francesco Caso, Luisa Costa, Paola Triggianese, Francesco Maione, Nicoletta Bertolini, Maria Vastarella, Maria Sole Chimenti & Marco Tasso. (2023) Recent developments for new investigational JAK inhibitors in psoriatic arthritis. Expert Opinion on Investigational Drugs 32:5, pages 361-371.
Read now
Luca Navarini, Damiano Currado, Luisa Costa, Marco Tasso, Maria Sole Chimenti & Francesco Caso. (2020) Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future. Journal of Experimental Pharmacology 12, pages 487-502.
Read now
Maria Sole Chimenti, Arianna D’Antonio, Paola Conigliaro, Sara Ferrigno, Andrea Vendola, Mario Ferraioli, Paola Triggianese, Luisa Costa, Francesco Caso & Roberto Perricone. (2020) An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis. Biologics: Targets and Therapy 14, pages 53-75.
Read now
Francesco Caso, Maria Sole Chimenti, Luca Navarini, Piero Ruscitti, Rosario Peluso, Nicolò Girolimetto, Antonio Del Puente, Roberto Giacomelli, Raffaele Scarpa & Luisa Costa. (2020) Metabolic Syndrome and psoriatic arthritis: considerations for the clinician. Expert Review of Clinical Immunology 16:4, pages 409-420.
Read now
Xingrui He, Xiabin Chen, Hancheng Zhang, Tian Xie & Xiang-Yang Ye. (2019) Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015–2018). Expert Opinion on Therapeutic Patents 29:2, pages 137-149.
Read now
Luisa Costa, Antonio Del Puente, Rosario Peluso, Marco Tasso, Paolo Caso, Maria Sole Chimenti, Vincenzo Sabbatino, Nicolò Girolimetto, Carolina Benigno, Nicoletta Bertolini, Aurora Del Puente, Roberto Perricone, Raffaele Scarpa & Francesco Caso. (2017) Small molecule therapy for managing moderate to severe psoriatic arthritis. Expert Opinion on Pharmacotherapy 18:15, pages 1557-1567.
Read now

Articles from other publishers (12)

Banzragch Dorjsembe, Haneul Joo, Chuwon Nho, Jungyeob Ham & Jin-Chul Kim. (2022) Aruncus dioicus var. kamtschaticus Extract Ameliorates Psoriasis-like Skin Inflammation via Akt/mTOR and JAK2/STAT3 Signaling Pathways in a Murine Model. Nutrients 14:23, pages 5094.
Crossref
Tingting Li, Si Gao, Wei Han, Zhenqiu Gao, Yundong Wei, Gang Wu, Wei Qiqiu, Li Chen, Yiping Feng, Shijiao Yue, Haixue Kuang & Xudong Jiang. (2022) Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis. Journal of Ethnopharmacology 294, pages 115275.
Crossref
Maria Sole Chimenti, Carlo Perricone, Paola Conigliaro, Paola Triggianese, Arianna D'Antonio, Erica de Martino, Giulia Lavinia Fonti, Francesco Caso, Luisa Costa & Roberto Perricone. (2020) Tackling the autoimmune side in Spondyloarthritis: A systematic review. Autoimmunity Reviews 19:10, pages 102648.
Crossref
Kalpana Pandey & Nimisha. (2020) An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis. Recent Patents on Nanotechnology 14:2, pages 102-118.
Crossref
Luca Navarini, Luisa Costa, Marco Tasso, Maria Sole Chimenti, Damiano Currado, Giulia Lavinia Fonti, Massimo Ciccozzi, Domenico Paolo Emanuele Margiotta, Carolina Benigno, Erica De Martino, Roberto Perricone, Antonella Afeltra, Raffaele Scarpa & Francesco Caso. (2020) Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting. Clinical Rheumatology 39:9, pages 2663-2670.
Crossref
Jing Jin, Nina Xue, Yuan Liu, Rong Fu, Mingjin Wang, Ming Ji, Fangfang Lai, Jinping Hu, Xiaojian Wang, Qiong Xiao, Xiaoying Zhang, Dali Yin, Liping Bai, Xiaoguang Chen & Shuan Rao. (2020) A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. Acta Pharmaceutica Sinica B 10:2, pages 276-288.
Crossref
Ettore Silvagni, Alessandra Bortoluzzi, Giovanni Ciancio & Marcello Govoni. (2019) Biological and synthetic target DMARDs in psoriatic arthritis. Pharmacological Research 149, pages 104473.
Crossref
Francesco Caso, Marco Tasso, Maria Sole Chimenti, Luca Navarini, Carlo Perricone, Nicolò Girolimetto, Rosario Peluso, Antonio Del Puente, Antonella Afeltra, Roberto Perricone, Leonardo Punzi, Raffaele Scarpa & Luisa Costa. (2019) Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management. Drugs & Aging 36:10, pages 909-925.
Crossref
Ritjona Mala, Monika Fida, Ekleva Jorgaqi & Ermira Vasili. (2019) Efficacy of biologic therapies in psoriasis vulgaris. Dermatologic Therapy, pages e12936.
Crossref
Gaetana Costanza, Elena Doldo, Amedeo Ferlosio, Chiara Tarquini, Daniela Passeri, Raffaella Cascella, Mauro Bavetta, Alessandro Di Stefani, Claudio Bonifati, Sara Agostinelli, Federica Centofanti, Emiliano Giardina, Elena Campione, Luca Bianchi, Pietro Donati, Aldo Morrone & Augusto Orlandi. (2018) Expression and potential role of cellular retinol binding protein I in psoriasis. Oncotarget 9:95, pages 36736-36749.
Crossref
Penghui Li, Yonglian Li, Hong Jiang, Yuting Xu, Xiaoying Liu, Biao Che, Jian Tang, Guangrong Liu, Yadong Tang, Wei Zhou, Langyue Zhang, Changzhi Dong, Huixiong Chen, Kun Zhang & Zhiyun Du. (2018) Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice. International Immunopharmacology 59, pages 243-251.
Crossref
Fernando Valenzuela, Javier Fernández & Pablo Santa María. (2018) Update on Oral Therapy for Psoriasis. Current Dermatology Reports 7:1, pages 52-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.